Literature DB >> 33731391

Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.

Cátia Ferrinho1, Eugénia Silva2, Manuela Oliveira2, João Sequeira Duarte2.   

Abstract

A 71-year-old woman was referred to the endocrinology clinic to investigate postmenopausal hirsutism with 10 years of evolution. She had history of regular menses and menopause with 50 years old. Physical examination showed a male pattern facies, deepening of the voice, androgenic alopecia and hirsutism with a score of 23 according to the modified Ferriman-Gallwey scale. Testosterone and androstenedione were increased. Transvaginal ultrasound, abdominal and pelvic CT showed uterine fibroids with no pathological findings in the adrenals or ovaries. Since she had postmenopausal vaginal bleeding, uterine fibroids and suspicion of an ovarian source for her hyperandrogenism, total hysterectomy and bilateral oophorectomy were performed. Histopathological diagnosis was a Leydig cell tumour located in left ovary and endometrial carcinoma. Improvement of hirsutism was started to notice 1 month after the surgery and she was referred to the oncology clinic for adjuvant treatment. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endocrinology; gynecological cancer; menopause (including HRT)

Mesh:

Substances:

Year:  2021        PMID: 33731391      PMCID: PMC7978078          DOI: 10.1136/bcr-2020-240937

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.

Authors:  Larisa V Suturina; Eldar M Sharifulin; Maharam A Sharifulin; Ludmila M Lazareva; Irina N Danusevich; Kseniia D Ievleva; Iana G Nadeliaeva
Journal:  Metabolites       Date:  2022-07-04

Review 2.  Comorbidities in Androgenetic Alopecia: A Comprehensive Review.

Authors:  Shuang Chen; Xiaohang Xie; Guoqiong Zhang; Yong Zhang
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.